[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
About the Journal & Policies
Editorial Board
Articles Archive::
Current Issue
All Issues
Guide for Authors::
Author instructions
Guide for publishing in journal
Submission Form
Author's consent form
For Reviewers::
Reviewers Section
Ethical Statements::
Registration::
Registration Form
Site Facilities::
Site map
Inform to friends
Contact us::
Contact Information
::
Indexed by
    
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Copyright Policies

 

AWT IMAGE

 
..
Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

..
:: Volume 13, Issue 1 (Winter 2024) ::
Shefaye Khatam 2024, 13(1): 1-4 Back to browse issues page
The Link Between the Gut Microbiome and Alzheimer's Disease
Faezeh Yaghoubi , Javad Momeni , Sayed Mostafa Modarres Mousavi *
Food Security and Agriculture Center, Tehran, Iran , modarres.mousavi@gmail.com
Abstract:   (509 Views)
Introduction: Alzheimer's disease (AD), one of the most common forms of dementia, has become a significant public health challenge. Given the rising prevalence of this disease, innovative research is exploring complex connections that could lead to a better understanding and treatment of AD. One such research area involves examining the impact of the gut microbiome on brain health, particularly its influence on AD. Recent studies have demonstrated a strong connection between the gut microbiome and AD, highlighting the potential for significant advancements in prevention and treatment. Conclusion: Recent studies suggest that changes in the composition of the gut microbiome may be associated with the progression of AD. Particularly, several investigations indicate that probiotics and certain diets can reduce brain inflammation and improve cognitive functioning in AD patients. These findings point to the importance of further investigating the relationship between the microbiome and AD. This could lead to the development of novel prevention and treatment methods.
 
Keywords: Neurodegenerative Diseases, Neuroinflammatory Diseases, Brain-Gut Axis, Probiotics
Full-Text [PDF 289 kb]   (189 Downloads)    
Type of Study: Letter to Editor --- Open Access, CC-BY-NC | Subject: Neurophysiology
References
1. L K, Ng TKS, Wee HN, Ching J. Gut-brain axis through the lens of gut microbiota and their relationships with Alzheimer's disease pathology: Review and recommendations. Mech Ageing Dev. 2023; 211: 111787. [DOI:10.1016/j.mad.2023.111787]
2. Abdolmaleki A, Tamjid M, Hamidi Bagehjan Z, Goodarzifard G, Zohreh R, Asadi A. Neurotransmitters: Types and Molecular Mechanisms of Secretion. The Neuroscience Journal of Shefaye Khatam. 2024. [DOI:10.61186/shefa.12.2.114]
3. Shirian S, Tahmasebian N, Bakhtiari Moghadm B, Kiani FZ, Amini MR. Anatomical, Physiological, and Pathological Changes in Different Parts of the Brain in Alzheimer's Disease. The Neuroscience Journal of Shefaye Khatam. 2024; 12(3): 103-16. [DOI:10.61186/shefa.12.3.103]
4. Fekete M, Lehoczki A, Major D, Fazekas-Pongor V, Csípő T, Tarantini S, et al. Exploring the Influence of Gut-Brain Axis Modulation on Cognitive Health: A Comprehensive Review of Prebiotics, Probiotics, and Symbiotics. Nutrients. 2024; 16(6). [DOI:10.3390/nu16060789]
5. Zhu F, Li C, Chu F, Tian X, Zhu J. Target dysbiosis of gut microbes as a future therapeutic manipulation in Alzheimer's disease. Frontiers in aging neuroscience. 2020; 12: 544235. [DOI:10.3389/fnagi.2020.544235]
6. Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, et al. Gut microbiome alterations in Alzheimer's disease. Scientific reports. 2017; 7(1): 13537. [DOI:10.1038/s41598-017-13601-y]
7. Grishin A, Papillon S, Bell B, Wang J, Ford HR. The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg. 2013; 22(2): 69-75. [DOI:10.1053/j.sempedsurg.2013.01.002]
8. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature reviews neuroscience. 2012; 13(10): 701-12. [DOI:10.1038/nrn3346]
9. Yaghoubi F, Jafarian M, Gorji A. The Anticonvulsant Effect of the Ketogenic Diet in the Treatment of Epilepsy. The Neuroscience Journal of Shefaye Khatam. 2020; 9(1): 200-9. [DOI:10.52547/shefa.9.1.200]
10. Mazrooei Rad E. Alzheimer's Disease Diagnosis Using Brain Signals and Artificial Neural Networks. The Neuroscience Journal of Shefaye Khatam. 2023; 11(3): 68-80. [DOI:10.61186/shefa.11.3.68]
11. Edalatmanesh MA. A Review of the Breast Milk Properties with Emphasis on the Neuroprotective Potential of Human Breast-Derived Stem Cells. The Neuroscience Journal of Shefaye Khatam. 2021; 9(2): 140-50. [DOI:10.52547/shefa.9.2.140]
12. Gao J, Zhao L, Cheng Y, Lei W, Wang Y, Liu X, et al. Probiotics for the treatment of depression and its comorbidities: A systemic review. Front Cell Infect Microbiol. 2023; 17; 13: 1167116. [DOI:10.3389/fcimb.2023.1167116]
13. Babakhani S, Hosseini F. Gut microbiota: An effective factor in the Human brain and behavior. The Neuroscience Journal of Shefaye Khatam. 2019; 7(1): 106-18. [DOI:10.29252/shefa.7.1.106]
14. Jiang C, Li G, Huang P, Liu Z, Zhao B. The Gut Microbiota and Alzheimer's Disease. J Alzheimers Dis. 2017; 58(1): 1-15. [DOI:10.3233/JAD-161141]
15. Amer M, Nadeem M, Nazir SUR, Fakhar M, Abid F, Ain QU, Asif E. Probiotics and Their Use in Inflammatory Bowel Disease. Altern Ther Health Med. 2018; 24(3): 16-23.
16. Caprara G. Mediterranean-Type Dietary Pattern and Physical Activity: The Winning Combination to Counteract the Rising Burden of Non-Communicable Diseases (NCDs). Nutrients. 2021; 13(2). [DOI:10.3390/nu13020429]
17. Shahverdi M, Sourani Z, Sargolzaie M, Modarres Mousavi M, Shirian S. An Investigation into the Effects of Water-and Fat-Soluble Vitamins in Alzheimer's and Parkinson's Diseases. The Neuroscience Journal of Shefaye Khatam. 2023; 11(3): 95-109. [DOI:10.61186/shefa.11.3.95]
18. Shirian S, Tahmasebian N, Bakhtiari Moghadm B, Kiani FZ, Amini MR. Anatomical, Physiological, and Pathological Changes in Different Parts of the Brain in Alzheimer's Disease. The Neuroscience Journal of Shefaye Khatam. 2024; 12(3): 103-16. [DOI:10.61186/shefa.12.3.103]
19. Shahverdi Shahraki M, Sourani Z, Behdarvand F, Modarres Mousavi M, Shirian S. The Potency of Biomarkers for the Diagnosis and Treatment of Parkinson's disease and Alzheimer's disease. The Neuroscience Journal of Shefaye Khatam. 2022; 10(2): 91-103. [DOI:10.61186/shefa.10.2.91]
20. Reddy DS, Abeygunaratne HN. Experimental and clinical biomarkers for progressive evaluation of neuropathology and therapeutic interventions for acute and chronic neurological disorders. International Journal of Molecular Sciences. 2022; 23(19): 11734. [DOI:10.3390/ijms231911734]
21. Coradduzza D, Sedda S, Cruciani S, De Miglio MR, Ventura C, Nivoli A, Maioli M. Age-Related Cognitive Decline, Focus on Microbiome: A Systematic Review and Meta-Analysis. Int J Mol Sci. 2023; 24(18). [DOI:10.3390/ijms241813680]
22. He J, Wu J, Liu J, Wu H, Hua H. Cognitive impairment and the gut-brain axis during 2014-2023: a bibliometric analysis. 2024; 15. [DOI:10.3389/fneur.2024.1407956]
23. Ullah H, Arbab S, Tian Y, Liu C-q, Chen Y, Qijie L, et al. The gut microbiota-brain axis in neurological disorder. 2023; 17. [DOI:10.3389/fnins.2023.1225875]
24. Zhang R, Ding N, Feng X, Liao W. The gut microbiome, immune modulation, and cognitive decline: insights on the gut-brain axis. 2025; 16. [DOI:10.3389/fimmu.2025.1529958]
25. Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal transduction and targeted therapy. 2024; 9(1): 37. [DOI:10.1038/s41392-024-01743-1]
26. Suganya K, Koo BS. Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. International Journal of Molecular Sciences. 2020; 21(20). [DOI:10.3390/ijms21207551]

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Yaghoubi F, Momeni J, Modarres Mousavi S M. The Link Between the Gut Microbiome and Alzheimer's Disease. Shefaye Khatam 2024; 13 (1) :1-4
URL: http://shefayekhatam.ir/article-1-2565-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 13, Issue 1 (Winter 2024) Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.05 seconds with 47 queries by YEKTAWEB 4710